[ad_1]
Limitless: ResApp co-founder Brian Leedman talks about the challenges of commercialising tech in Perth after the company was acquired by Pfizer for $179 million.
[ad_2]
Source link
[ad_1]
Limitless: ResApp co-founder Brian Leedman talks about the challenges of commercialising tech in Perth after the company was acquired by Pfizer for $179 million.
[ad_2]
Source link